TORCH testing in HIV-infected women

Clinical Obstetrics and Gynecology

Volumn 42, Issue 1, 1999, Pages 149-162

  Helfgott, Andrew ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Lyndon B Johnson General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

CYTOMEGALOVIRUS INFECTION; FEMALE; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAUTERINE INFECTION; REVIEW; SYPHILIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HERPES SIMPLEX; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROLOGIC TESTS; SYPHILIS; TOXOPLASMOSIS;

EID: 0033375237     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199903000-00019     Document Type: Review

References (69)

1. Karon JM, Rosenberg PS, McQuillan G, et al. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA. 1996; 276:126-131.
2. Kaplan JE, Masur H, Holmes KK, et al. USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency syndrome. Clin Infect Dis. 1994;18:421.
3. Selik RM, Chu SY, Ward JW, et al. Trends in infectious diseases and cancer among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med. 1995;123:933-936.
4. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 1996;124:633-642.
5. CDC 1997 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR. 1997;46(RR-12):1-46.
6. Jones JL, Hanson DL, Ward JW, et al. Incidence trends in AIDS related opportunistic illnesses in injecting drug users and men who have sex with men. [Abstract We. C. 3418]. Vol 2 XI International Conference on AIDS. Vancouver, July 7-12, 1996.
7. Luft BJ, Castro KG. An overview of the problem of toxoplasmosis and Pneumocystis in AIDS in the USA: Implications for future therapeutic trials. Euro J Mircroiol Infect Dis. 1991;10:178-181.
8. Luft BJ, Remington JS. AIDS commentary: Toxoplasmic encephalitis. J Infect Dis. 1988;157:1-6.
9. Gallant JE, Moore RD, Richmann DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus treated with zidovudine. J Infect Dis. 1992; 166:1223-1227.
10. CDC 1993 Revised Classification System for human immunodeficiency virus infection and expanded surveillance, case definition for AIDS among adolescents and adults. MMWR. 1992;(RR-12):1-19.
11. Frenkel JK, Nelson BM, Arias-Stella J. Immunosuppression and toxoplasmic encephalitis. Human Pathol. 1975;6:97-111.
12. Kaspar LH. Toxoplasma and toxoplasmosis. In: Isselbacher KJ, Brauwald E, Wilson J, Martin JB, Fauci AS, Kaspar DL, eds. Harrison's Principles of Internal Medicine, 13th edition. New York, NY: McGraw-Hill, 1994:903-908.
13. Murray HW, Rubin BY, Masur H, et al. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med. 1984;310:883-889.
14. Lignappa JR, Sande MA. Toxoplasmosis. In: Cohen PT, Sande MS, Volberding PA, eds. The AIDS Knowledge Base, 2nd edition. : Little, Brown and Company, 1995.
15. Clumeck N. Some aspects of the epidemiology of toxoplasmosis and pneumocystosis in AIDS in Europe. Eur J Clin Microbiol Infect Dis. 1991;10:177-178.
16. Israelski DM, Chmiel JS, Poggensee L, Phair JP, Remington J. Prevalence of Toxoplasma infection in a cohort of risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr. 1993;6:414-418.
17. Wong SY, Remington JS. Toxoplasmosis in the setting of AIDS. In: Border S, Merigan TC, Bolonesi D, eds. Textbook of AIDS Medicine. Baltimore, MD: Williams and Wilkins, 1994:223-257.
18. Grant JH, Gold J, Rosenblum M, et al. Toxoplasma gondii serology in HIV-infected patients: The development of central nervous system toxoplasmosis. AIDS. 1990;4:519-521.
19. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:1643-1648.
20. Danneman BR, Israelski DM, Leoung L, et al. Toxoplasma serology, parasitemia, and antigenemia in patients at risk for Toxoplasma encephalitis. AIDS. 1991;5:1363-1365.
21. Hellerbrand C, Goebel FD, Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1996;15:869-872
22. DeRouin F, Thulliez PH, Garin YJ. Interet et limites de la serologic de toxoplasmse chez les sujets VIH+. Path Biol. 1991;39: 255-259.
23. DeRouin F, Leport C, Pueyo S, et al. Predictive value of Toxoplasma gondii antibody titers on the occurrence of toxoplasmic encephalitis in HIV-infected patients. AIDS. 1996;10:1521-1527.
24. Lamoril J, Molina JM, Gourello A, et al. Detection of PCR of Toxoplasma gondii in blood in the diagnosis of cerebral toxoplasmosis in patients with AIDS. J Clin Pathol. 1996;49:89-92.
25. Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA. 1993;269:76-77.
26. Marty P, Bongain A, Rahal A, Thulliez P, et al. Prenatal diagnosis of severe fetal toxoplasmosis as a result of Toxoplasmic reactivation in an HIV-1 seropositive woman. Prenat Diagn. 1994;14:414-415.
27. Mitchell CD, Erlich SS, Mastrucci MT, et al. Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus. Pediatr Infect Dis J. 1990;9:129-132.
28. Medlock MD, Tillel JT, Pearl GS. Congenital cardiac toxoplasmosis in a newborn with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1990;9:129-132.
29. Mitchell CD, Lewis L, McLlellan L, et al. Increased risk of congenital toxoplasmosis among infants born to mothers infected with HIV-1 and Toxoplasma gondii (abstract). Program of the Third Conference on Retroviruses and Opportunistic Infections. Washington, DC. Jan-Feb, 1996.
30. European Collaborative Study and Research Network on Congenital Toxoplasmosis. Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. Euro J Obstet Gynecol Reprod Biol. 1996;68:93-96.
31. Minkoff H, Renmington JS, Holman S, et al. Vertical transmission of Toxoplasma by human immunodeficiency virus-infected women. Am J Obstet Gynecol. 1997;176: 555-559.
32. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;108:585-594.
33. Peters BS, Beck EJ, Anderson S, et al. Cytomegalovirus infection in AIDS patients: Patterns of disease, response to therapy, and trends in survival. J Infect. 1991; 23:129-137.
34. Wentworth BB, Alexander ER. Seroepidemiology of infections due to members of the herpesvirus group. Am J Epidemiol. 1971; :496-502.
35. Drew WL, Mintz L, Minter RC, et al. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis. 1981;143:188-192.
36. Gallant JE, Moore RD, Richman D, et al. Zidovudine Epidemiology Study Group: Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency disease treated with zidovudine. J Infect Dis. 1992;166: 1223-1227.
37. Mintz L, Drew WL, Minter RC, Braff EH. Cytomegalovirus infections in homosexual men: An epidemiologic study. Ann Intern Med. 1983;99:326-329.
38. Hirsh MS. Cytomegalovirus infection. In: Isselbacher KJ, Bruanwald E, Wilson JD, Martin JB, Fauci AB, Kaspar DL, eds. Harrison's Principles of Internal Medicine, 13th edition. New York, NY: McGraw-Hill, 1994:794-798.
39. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbol. 1984;19:917-919.
40. Zurlo JJ, O'Neill D, Polis MA, et al. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med. 1993; 118:12-17.
41. Drew WL, Jacobson MA. Cytomegalovirus. In: Cohen PT, Sande MA, Volerding P, eds. AIDS Knowledge Book, 2nd Edition. Boston, MA: Little, Brown and Company, 1996:6.13-1 to 6.13-12.
42. Shinkai M, Bozzette SA, Powderly W, et al. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk of developing cytomegalovirus disease. J Infect Dis. 1997;175:302-308.
43. Spector SA, Merrill R, Wolf D, Dankner WM. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol. 1992; :2359-2365.
44. Kupperman BD, Petty JG, Richman DD, et al. Correlation between CD4 counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115:575-582.
45. Salmon D, Lacassin F, Harzic M, et al. Predictive value of cytomegalovirus viremia for the occurrence of CMV organ involvement in AIDS. J Med Virol. 1990;32: 160-163.
46. Stewart JA, Rief SE, Pellet PE, et al. Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995;21(supp):S114-S120.
47. Safrin S, Ashley R, Houlihan C, et al. Clinical and serologic features of herpes simplex virus infection in patients with AIDS. AIDS. 1991;5:1107-1110.
48. Johnson RE, Nahmias AJ, Magder LS, et al. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infections in the United States. N Engl J Med. 1989;321:7-12.
49. Augunbraun M, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med. 1995;123:845-847.
50. Erlick KS, Safrin S, Mills J. Herpes simplex virus. In: Cohen PT, Sande MA, Volberding PA, eds. AIDS Knowledge Base. 2nd edition. Boston, MA: Little, Brown Company, 1996:6.12-1-19.
51. Armstrong D, Gold JW, Dryjanski J, et al. Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103:738-743.
52. Bagdades EK, Pillay D, Squire SB, et al. Relationship between herpes simplex virus ulceration and CD4 T cell counts in patients with HIV infection. AIDS. 1992;6:1317-1320.
53. Nahmias AJ, Whitley RJ, Visintine AN et al. Herpes simplex virus encephalitis: Laboratory evaluations and their diagnostic significance. J Infect Dis. 1982;145:829-836.
54. Connolly GM, Hawkins D, Harcourt-Webster JN, et al. Esophageal symptoms, their cause, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. Gut. 1989;30:1033-1039.
55. Shifrin S. Herpes simplex and varicella zoster infections in HIV-infected individuals. In: Border S, Merigan TC, Bolognes D, eds. Textbook of AIDS Medicine. Baltimore, MD: Williams & Wilkins, 1994:373-383.
56. Rowley AH, Whitley RJ, Lakeman FD, Wolinsky SM. Rapid detection of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet. 1990;335:440-441.
57. Darrow WW, Eschenberg DF, Jarrow HW, et al. Risk factors for human immunodeficiency virus in homosexual men. Am J Public Health. 1987;77:475-483.
58. Stamm WE, Handfield HH, Rompalo AM, et al. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA. 1988;260:1429-1433.
59. Centers for Disease Control. Syphilis and congenital syphilis. United States, 1985-1988; MMWR. 37:486-489.
60. Hook EW. Management of syphilis in the human immunodeficiency virus-infected patient. Am J Med. 1992;93:477-478.
61. Musher DM, Hammill RJ, Baughn RE. Effects of human immunodeficiency virus infection on the course of syphilis and on the response to treatment. Ann Intern Med. 1990;113:872-881.
62. Johns DR, Tierney M, Felerstein D. Alteration in the natural history of neurosyphilis by concurrent infection with human immunodeficiency virus. N Engl J Med. 1987; 316:1569-1572.
63. Pavia CS, Folds JD, Besemen JB. Cell-mediated immunity during syphilis. Br J Vener Dis. 1978;54:144-150.
64. Gregory N, Sanchex M, Buchness MR. The spectrum of syphilis in patients with human immunodeficiency virus infection. J Am Acad Dermatol. 1990;22:1061-1067.
65. Hicks CB, Benson PM, Lupton GP, et al. Seronegative secondary syphilis in a patient infected with HIV with Kaposi Sarcoma. Am J Intern Med. 1987;107:492-495.
66. Rudolf JD, Kaplan P. Unusual manifestations of secondary syphilis and abnormal humoral response to T. pallidum in antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol. 1988;18: 423-428.
67. Hass JS, Bolan G, Larsen SA, et al. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis. 1990; 162:862-866.
68. Burstain JM, Griprel E, Lukehart SA, et al. Sensitive detection of Treponema pallidum by using the polymerase chain reaction. J Clin Microbiol. 1991;29:62-69.
69. Hay PE, Clarke JR, Taylor-Robinson D. Detection of treponemal DNA in the CSF of patients with syphilis and HIV infection using the polymerase chain reaction. Genitourin Med. 1990;66:428-432.